Publication: Unraveling the bioactivity of anticancer peptides as deduced from machine learning
Issued Date
2018-07-25
Resource Type
ISSN
16112156
Other identifier(s)
2-s2.0-85051506666
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
EXCLI Journal. Vol.17, (2018), 734-752
Suggested Citation
Watshara Shoombuatong, Nalini Schaduangrat, Chanin Nantasenamat Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI Journal. Vol.17, (2018), 734-752. doi:10.17179/excli2018-1447 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/44712
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Unraveling the bioactivity of anticancer peptides as deduced from machine learning
Other Contributor(s)
Abstract
© 2018, Leibniz Research Centre for Working Environment and Human Factors. All rights reserved. Cancer imposes a global health burden as it represents one of the leading causes of morbidity and mortality while also giving rise to significant economic burden owing to the associated expenditures for its monitoring and treatment. In spite of advancements in cancer therapy, the low success rate and recurrence of tumor has necessitated the ongoing search for new therapeutic agents. Aside from drugs based on small molecules and protein-based biopharmaceuticals, there has been an intense effort geared towards the development of peptide-based therapeutics owing to its favorable and intrinsic properties of being relatively small, highly selective, potent, safe and low in production costs. In spite of these advantages, there are several inherent weaknesses that are in need of attention in the design and development of therapeutic peptides. An abundance of data on bioactive and therapeutic peptides have been accumulated over the years and the burgeoning area of artificial intelligence has set the stage for the lucrative utilization of machine learning to make sense of these large and high-dimensional data. This review summarizes the current state-of-the-art on the application of machine learning for studying the bioactivity of anticancer peptides along with future outlook of the field. Data and R codes used in the analysis herein are available on GitHub at https://github.com/Shoombuatong2527/anticancer-peptides-review.